Adapting Analytical Strategies to Keep Pace with AAV Complexity & Maintain Confidence

• Addressing how capsid and genome changes are affecting the reliability of existing assays
• Redesigning analytical and stability methods to reflect new product behaviors and risks
• Maintaining consistency in measurement to support confident decision making despite variability

Speakers:

Jorge Santiago-Ortiz

Vice President, CMC & Regulatory Affairs

Apertura Gene Therapy